Then we divided the 20 CRC patients into MARCH1 high and low expression groups according to the expression levels of MARCH1 (as per the mean ± SD values) in CRC tissues as per western blot analysis results and analyzed the relationship between the expression of MARCH1 and clinicopathological characteristics (Table 1). Here, MARCHF1 is linked to colorectal carcinoma.